Kamada (KMDA) Change in Inventory (2013 - 2026)
Kamada (KMDA) posted quarterly Change in Inventory of -$494000.0 for Q1 2026, down 207.16% year-on-year from $461000.0 in Q1 2025, and down 205.33% on a QoQ basis from $469000.0 in Q4 2025.
Kamada (KMDA) Change in Inventory (2013 - 2026) Analysis & Trends
Kamada (KMDA) has reported Change in Inventory for 14 consecutive years, with -$494000.0 the latest figure, recorded in Q1 2026.
- Quarterly Change in Inventory fell 207.16% year-over-year to -$494000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.1 million (down 218.2% YoY) and the FY2025 annual result came in at -$6.1 million, down 163.4% from the prior year.
- Change in Inventory eased to -$494000.0 in Q1 2026 per KMDA's latest filing, from $469000.0 in the prior quarter.
- Over the last five years, Change in Inventory for KMDA reached as high as $7.2 million in Q3 2024 and fell as low as -$14.7 million in Q4 2023.
- A 5-year average of -$164425.5 and a median of $4245.0 in 2022 frame the typical range for Change in Inventory.
- The largest YoY upside for Change in Inventory was 75796.32% in 2023 against a maximum downside of 345989.28% in 2023.
- Year by year, Change in Inventory stood at $4245.0 in 2022, then slumped by 345989.28% to -$14.7 million in 2023, then jumped by 50.55% to -$7.3 million in 2024, then soared by 106.46% to $469000.0 in 2025, then plunged by 205.33% to -$494000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$494000.0, $469000.0, and -$3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -494,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -494,000.00 |
| Mar 31, 2026 | -494,000.00 |
| Dec 31, 2025 | 469,000.00 |
| Dec 31, 2025 | 469,000.00 |
| Sep 30, 2025 | -3.33 Mn |
| Sep 30, 2025 | -3.33 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Mar 31, 2025 | 461,000.00 |
| Mar 31, 2025 | 461,000.00 |
| Dec 31, 2024 | -7.26 Mn |
| Dec 31, 2024 | -7.26 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | -14.68 Mn |
| Dec 31, 2023 | -14.68 Mn |